News

Medical Device Network2d
EpiPen patent expiry opens new era for innovation
The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.
Medical Device Network2d
Boehringer and Click seek schizophrenia PDT approval after Phase III success
Boehringer and Click's CT-155 plus antipsychotics significantly reduced negative symptoms associated with schizophrenia in a Phase III trial ...
Medical Device Network2d
Zimmer Biomet raises 2025 outlook amid strong portfolio growth
Zimmer has lifted its 2025 outlook due to growth in its sports medicine, extremities, trauma, craniomaxillofacial and thoracic business.
Medical Device Network2d
Natera introduces prenatal test for detecting inherited conditions
Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to the company, when a pregnant individual is found to carry a ...
Medical Device Network2d
Annabel Kartal Allen, Author at Medical Device Network
The leading site for news and procurement in the medical device industry ...
Medical Device Network2d
HistoSonics announces acquisition by investor consortium for $2.25bn
HistoSonics has announced a majority stake acquisition by a consortium involving a transaction that values the company at $2.25bn.
Medical Device Network3d
China NMPA approves Bracco Imaging’s contrast agent for infertility diagnosis
China's NMPA has approved Bracco Imaging's ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles.
Medical Device Network3d
Medical Device Network
Zimmer Biomet has lifted its 2025 profit outlook to between 6.7% and 7.7%, up from 5.7% to 8.2%, driven by strong growth in its sports medicine, extremities, trauma, craniomaxillofacial and thoracic ...